[1] |
LIU Ming, ZHENG Li, ZHANG Weina, SUN Xuelin, TIAN Jinhui, ZHAO Yan.
Research Progress in Biological Activity and Mechanisms of Pachymic Acid
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 826-830.
|
[2] |
ZHENG Changhui, MA Lina, HE Ting, GU Yuanyuan, ZHAO Wei, WANG Hongbin, NIU Yuanfei, FU Yao, CHEN Yanjun, CAO Junling.
Quality Evaluation and Control of Bupleuri Radix Decoction Pieces Based on ‘Shape-Chemistry-Biology' Sequential Detection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 197-205.
|
[3] |
LIANG Xiao, LI Li, XU Xiaolong, BAI Yinglu, YANG Yumei, ZHU Yong, LIU Qingquan.
Advancements in Treatment of Brucellosis with Traditional Chinese Medicine
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 231-234.
|
[4] |
YU Wenlu, ZHANG Hong.
Research Progress in Applications of Strychnine Semen in Orthopedics and Traumatology
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 116-120.
|
[5] |
CHEN Chongze, ZHOU Tianyu, SUN Siman, GUO Shushu, JIN Hongtao.
Risk Signal Mining of Adverse Events Related to Levothyroxine Sodium Tablets Based on FAERS
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(12): 1425-1431.
|
[6] |
GE Yunxuan, WANG Yuguang, ZHANG Zhuo, MA Zengchun, GAO Yue.
Effect of hypaconitine of radix aconiti carmichaeli on hERG channels in cardiac myocytes via miR-134 regulation
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 606-610.
|
[7] |
LIU Yang, FAN Zheng, WANG Honglei, YANG Ying, GUO Qi, CHANG Xinyu, HAN Lijuan, LI Wenzhe, WU Jiankun.
Therapeutic effect of Jingzhui Kangfu pills against osteoarthritis induced by proteoglycan in mice
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 651-654.
|
[8] |
HU Xiaozhen, MA Lina, HE Ting, GU Yuanyuan, ZHAO Wei, ZHENG Changhui, YE Zuguang, CAO Junling.
Literature research on ancient and modern literature of Dichroae Radix and Shu lacquer
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 587-593.
|
[9] |
LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo.
Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180.
|
[10] |
CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili.
One case of severe liver injury caused by Tianma Shouwu tablets
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218.
|
[11] |
ZUO Tiantian, WANG Zhao, GUO Yuansheng, WEI Feng, JIN Hongyu, MA Shuangcheng.
Non-carcinogenic and carcinogenic risk assessment of toxic elements in Panax quinquefolium L. based on multi-element semi-quantitative screening
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1108-1112.
|
[12] |
CAO Lin, RAN Zheng, HOU Qiang, QIU Zuocheng, YANG Jianhua.
Chemical composition of Huatie compound and prediction of potential mechanism for prevention and treatment of hyperplasia of mammary glands
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1113-1120.
|
[13] |
HUANG Jinjian, ZHANG Xiaomeng, ZHANG Bing, DING Xueli, YANG Ying, LIN Zhijian.
Cardiovascular risk signaling mining and mechanism of uric acid-lowering drugs
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 866-871.
|
[14] |
ZOU Dongmei, FANG Fang, GUO Yixian, NI Jing, ZHAO Hong, HU Ronghua, SUN Wanling.
Analysis of the association of adverse reactions with relative dose of melphalan and body weight in POEMS syndrome patients undergoing melphalan-based ASCT
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 911-914.
|
[15] |
ZUO Zeping, TIAN Yingying, XU Yi, JIANG Kewu, YANG Shuo, YANG Hairun, ZHANG Zhicong, CAO Xinyao, WU Xiaoru, WANG Zhibin.
Preclinical safety evaluation of Jinkui Shenqi pills
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 775-782.
|